Cargando…

Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics

Schizophrenia has been conceptualized as a neurodevelopmental disorder with synaptic alterations and aberrant cortical–subcortical connections. Antipsychotics are the mainstay of schizophrenia treatment and nearly all share the common feature of dopamine D2 receptor occupancy, whereas glutamatergic...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Bartolomeis, Andrea, Vellucci, Licia, Austin, Mark C., De Simone, Giuseppe, Barone, Annarita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312470/ https://www.ncbi.nlm.nih.gov/pubmed/35883465 http://dx.doi.org/10.3390/biom12070909

Ejemplares similares

Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
por: De Simone, Giuseppe, et al.
Publicado: (2023)

Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2023)

Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal
por: Iasevoli, Felice, et al.
Publicado: (2023)

Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance
por: de Bartolomeis, Andrea, et al.
Publicado: (2022)

The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
por: Vellucci, Licia, et al.
Publicado: (2023)

Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment
por: de Bartolomeis, Andrea, et al.
Publicado: (2023)

Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2023)

Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
por: de Bartolomeis, Andrea, et al.
Publicado: (2022)

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2020)

A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration
por: Barone, Annarita, et al.
Publicado: (2023)

S205. A TRANSLATIONAL HOMER 1A-BASED NETWORK APPROACH: IMAGING HOW HALOPERIDOL MODULATES GLUTAMATE SYSTEM FUNCTIONAL CONNECTIVITY
por: Vellucci, Licia, et al.
Publicado: (2020)

The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted
por: Iasevoli, Felice, et al.
Publicado: (2020)

S202. PROXIMAL AND DISTAL FACTORS ASSOCIATED WITH CLOZAPINE EXPOSURE IN A SAMPLE OF TREATMENT RESISTANT AND TREATMENT RESPONSIVE SCHIZOPHRENIA PATIENTS
por: Barone, Annarita, et al.
Publicado: (2020)

F234. TYPICAL AND ATYPICAL ANTIPSYCHOTICS’ D2R AFFINITY AND DOSES INFLUENCES POSTSYNAPTIC DENSITY BY MODULATING THE SPATIAL EXPRESSION OF HOMER1A A GENE HIGHLY IMPLICATED IN SYNAPTIC PLASTICITY AND PSYCHOSIS
por: Camilla, Avagliano, et al.
Publicado: (2018)

Neurobiological Implications of Parent–Child Emotional Availability: A Review
por: Clark, Emma L. M., et al.
Publicado: (2021)

Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study
por: Tranfa, Mario, et al.
Publicado: (2023)

Biomarkers and neurobiology of schizophrenia
por: Falkai, Peter, et al.
Publicado: (2012)

O9.4. RELATIONSHIPS BETWEEN AGE AT ONSET OF PSYCHOTIC SYMPTOMS AND POOR RESPONSE TO ANTIPSYCHOTICS IN A SAMPLE OF TRS/NON-TRS PATIENTS
por: Iasevoli, Felice, et al.
Publicado: (2020)

High-frequency oscillations and the neurobiology of schizophrenia
por: Uhlhaas, Peter J., et al.
Publicado: (2013)

The neurobiology and treatment of first-episode schizophrenia
por: Kahn, R S, et al.
Publicado: (2015)

Neurobiological Determinants of Tobacco Smoking in Schizophrenia
por: Lucatch, Aliya M., et al.
Publicado: (2018)

Neurobiology of Schizophrenia: A Comprehensive Review
por: Luvsannyam, Enkhmaa, et al.
Publicado: (2022)

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
por: Iasevoli, Felice, et al.
Publicado: (2014)

The Neurobiological Basis of Cognitive Side Effects of Electroconvulsive Therapy: A Systematic Review
por: Bassa, Adriana, et al.
Publicado: (2021)

The effects of sustained COVID‐19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study
por: Barone, Annarita, et al.
Publicado: (2022)

Neurobiological mechanisms underlying delayed expression of posttraumatic stress disorder: A scoping review
por: Smid, Geert E, et al.
Publicado: (2022)

Neurobiology of schizophrenia: from outcome to pathophysiological insights
por: Falkai, P., et al.
Publicado: (2012)

Neurobiology of Schizophrenia: Search for the Elusive Correlation with Symptoms
por: Mathalon, Daniel H., et al.
Publicado: (2012)

F233. NEGATIVE SYMPTOMS ARE INDEPENDENT MODERATOR FACTORS OF TREATMENT RESISTANT SCHIZOPHRENIA EFFECTS ON MULTIPLE CLINICAL, PSYCHOPATHOLOGICAL, COGNITIVE AND PSYCHOSOCIAL VARIABLES
por: Iasevoli, Felice, et al.
Publicado: (2018)

A Neurobiological Model of Alcohol Marketing Effects on Underage Drinking
por: Courtney, Andrea L., et al.
Publicado: (2020)

Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
por: Iasevoli, Felice, et al.
Publicado: (2018)

D-Amino Acids as a Biomarker in Schizophrenia
por: Taniguchi, Kurumi, et al.
Publicado: (2022)

Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia
por: Iasevoli, Felice, et al.
Publicado: (2021)

Exploring rationality in schizophrenia
por: Revsbech, Rasmus, et al.
Publicado: (2015)

Current understandings about cognition and the neurobiological correlates in schizophrenia
por: Kar, Sujita Kumar, et al.
Publicado: (2016)

The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update
por: Silverstein, Steven M., et al.
Publicado: (2021)

The Influence of Sleep Disorders on Neurobiological Structures and Cognitive Processes in Pediatric Population with ASD and Epilepsy: A Systematic Review
por: López-Zamora, Miguel, et al.
Publicado: (2023)

M139. DIFFERENTIAL PATTERNS OF BRAIN METABOLISM IN STABILIZED, ACTIVELY SYMPTOMATIC TREATMENT RESISTANT VS. TREATMENT RESPONDER SCHIZOPHRENIA PATIENTS: A STUDY BY 18F-FDG-POSITRON EMISSION TOMOGRAPHY AND STRUCTURAL 3T MRI
por: Iasevoli, Felice, et al.
Publicado: (2020)

S228. TOWARD EARLY DETECTION OF TREATMENT RESISTANT SCHIZOPHRENIA: PREDICTIVE INFORMATION ON NON-RESPONSE TO ANTIPSYCHOTICS BY EVALUATION OF A FEW CLINICAL FACTORS: A STUDY BY ROC CURVE ANALYSIS AND CONFIRMATORY MULTIVARIATE ANALYSIS
por: Iasevoli, Felice, et al.
Publicado: (2018)

The Neurobiology of Opioid Dependence: Implications for Treatment
por: Kosten, Thomas R., et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_8mais20m6nqf74dlufqufnk5cb